同源康医药-B涨超3% 拟折让19%配股净筹约1.55亿港元 用于现有管线研发及商业化等

智通财经
Jul 30, 2025

同源康医药-b(02410)涨超3%,截至发稿,涨2.34%,报21.85港元,成交额3234.21万港元。消息面上,同源康医药-b发布公告,于2025年7月28日,公司与配售代理订立配售协议,据此,配售代理有条件同意作为公司的配售代理,按尽力基准促使承配人按每股配售股份17.01港元的配售价购买923万股配售股份。假设于本公告日期至交割日期期间已发行股份数目并无变动,则配售事项项下的923万股...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10